PHARMExcel provides Medical Affairs support for sponsors conducting clinical trials. Within this broad umbrella, our specific offering is clinical monitoring, also known as CRA monitoring, delivered through a hybrid model that combines remote, central and on-site monitoring to ensure the right level of oversight for each trial based on risk. This support sits within the clinical trial stage, where monitoring expertise is needed to help maintain participant safety, support protocol compliance and ensure that study conduct remains aligned with both the intent of the protocol and the realities of clinical care.
We work with biotechs, medtech companies, charities and NHS or academic sponsors, as well as US and EU-based organisations, to provide medical input that is closely connected to trial delivery. Our approach is practical and study-focused, combining risk-adapted clinical monitoring with cross-functional collaboration to support well-governed clinical research.
Medical oversight in clinical trials
Medical input during a trial can influence much more than isolated safety decisions. It plays an important role in how protocols are interpreted, how clinically significant events are reviewed and how emerging issues are escalated during study conduct. In more complex studies, particularly those involving higher-risk interventions, vulnerable populations or specialist treatment pathways, this medical oversight becomes even more important.
PHARMExcel supports sponsors with medical input that is grounded in the day-to-day running of clinical studies. This includes close collaboration with project teams, safety functions and investigators so that medical considerations are reflected clearly in how the study is managed. The aim is to support consistent decision-making and maintain a strong level of clinical oversight throughout trial delivery.
Clinical monitoring (CRA monitoring) and patient safety
Clinical monitoring, delivered by experienced CRAs (Clinical Research Associates), is the core way in which PHARMExcel delivers Medical Affairs support during clinical trials. We use a hybrid monitoring model that combines remote monitoring, central monitoring and on-site monitoring visits to ensure the right level of oversight for each trial based on its specific risk profile. This approach helps sponsors and project teams maintain data quality, assess protocol adherence, review safety data and address study conduct issues as they arise.
This work helps ensure that participant safety remains central to the trial while also supporting clearer and more timely decision-making at site level. Because clinical monitoring is closely linked to safety management, project delivery and regulatory expectations, it works best when it is fully integrated into the wider study team. At PHARMExcel, that integration is part of the way we work, and our hybrid model ensures that monitoring intensity can be scaled appropriately throughout the life of the study.
Cross-functional scientific support during study delivery
Clinical monitoring does not sit in isolation. It often overlaps with safety reporting, protocol interpretation, participant eligibility questions, investigator discussions and the clinical implications of emerging study data. PHARMExcel supports sponsors by providing CRA monitoring that works alongside project management, pharmacovigilance and regulatory teams, so that trial decisions are better informed and more consistent.
This joined-up approach is particularly valuable in studies where the clinical context is changing quickly or where safety, compliance and operational feasibility need to be considered together. It also helps ensure that communication between medical, operational and regulatory teams remains clear throughout the life of the study.
Scientific engagement with investigators and specialist networks
PHARMExcel’s medical affairs support is also informed by our experience of working with specialist investigators, research-active sites and clinical teams across a range of therapeutic areas. While we do not position this service as broad commercial KOL engagement, our work does involve ongoing scientific dialogue with the clinicians and site teams responsible for study delivery.
This can be valuable during both planning and active study conduct, particularly where sponsors need medically grounded input on protocol practicality, patient pathways or the feasibility of delivering the study within specialist centres. In this sense, PHARMExcel’s strength lies in medically informed trial support that is closely connected to real site environments rather than broader market-facing medical affairs activity.
Supporting safety review and medically informed governance
Medical affairs support within clinical trials also plays a role in governance. Trials need clear escalation routes for clinically important issues, and higher-risk studies may require more formal structures for independent review or ongoing medical input. PHARMExcel supports sponsors with medically informed governance processes that help studies remain safe, compliant and well controlled as they progress.
This includes working alongside safety management processes, supporting the interpretation of significant events and contributing to the broader oversight framework around the study. Because PHARMExcel already works closely with sponsors on monitoring, safety management and trial operations, medical input can be embedded in a way that remains proportionate to the complexity of the project.
Why sponsors choose PHARMExcel for medical affairs support
Sponsors choose PHARMExcel because we combine clinical understanding, practical trial experience and a quality-driven approach to study oversight. As a smaller, specialist CRO based in the UK, we offer direct access to experienced senior staff, continuity of team and the flexibility and personal service that larger organisations often struggle to match.
That model is particularly helpful in studies where medical input needs to be responsive, well integrated and closely aligned with the way the trial is actually being delivered. Rather than treating medical affairs as a standalone commercial function, PHARMExcel provides medical support in a way that strengthens trial oversight, participant protection and operational clarity.
Our aim is to help sponsors run clinical trials that are not only scientifically robust, but also well supported from a medical and clinical governance perspective.
Looking for experienced medical affairs support?
Whether you need medical oversight for a single study or ongoing support across your clinical programme, PHARMExcel’s medical experts are here to help. Contact our team to discuss your requirements and discover how we can provide the expertise needed to support safe, high-quality clinical research.